2269.HK
Price:
$27.75
Market Cap:
$103.17B
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Bioscienc...[Read more]
Industry
Biotechnology
IPO Date
2017-06-13
Stock Exchange
HKSE
Ticker
2269.HK
According to WuXi Biologics (Cayman) Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.73. This represents a change of 3.02% compared to the average of 2.65 of the last 4 quarters.
The mean historical Current Ratio of WuXi Biologics (Cayman) Inc. over the last ten years is 2.61. The current 2.73 Current Ratio has changed 10.39% with respect to the historical average. Over the past ten years (40 quarters), 2269.HK's Current Ratio was at its highest in in the June 2018 quarter at 5.89. The Current Ratio was at its lowest in in the January 2014 quarter at 0.
Average
2.61
Median
2.76
Minimum
0.50
Maximum
4.36
Discovering the peaks and valleys of WuXi Biologics (Cayman) Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 266.80%
Maximum Annual Current Ratio = 4.36
Minimum Annual Increase = -43.06%
Minimum Annual Current Ratio = 0.50
Year | Current Ratio | Change |
---|---|---|
2024 | 2.73 | -1.50% |
2023 | 2.78 | 40.06% |
2022 | 1.98 | -16.21% |
2021 | 2.37 | -25.09% |
2020 | 3.16 | -6.26% |
2019 | 3.37 | -22.68% |
2018 | 4.36 | 14.62% |
2017 | 3.80 | 266.80% |
2016 | 1.04 | 107.20% |
2015 | 0.50 | -43.06% |
The current Current Ratio of WuXi Biologics (Cayman) Inc. (2269.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.50
5-year avg
2.60
10-year avg
2.61
WuXi Biologics (Cayman) Inc.’s Current Ratio is greater than WuXi AppTec Co., Ltd. (2.29), greater than Innovent Biologics, Inc. (2.35), greater than Alibaba Health Information Technology Limited (2.45), greater than Sino Biopharmaceutical Limited (1.26), greater than Meituan (1.94),
Company | Current Ratio | Market cap |
---|---|---|
2.29 | $212.82B | |
2.35 | $133.37B | |
2.45 | $76.53B | |
1.26 | $101.76B | |
1.94 | $861.49B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like WuXi Biologics (Cayman) Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like WuXi Biologics (Cayman) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is WuXi Biologics (Cayman) Inc.'s Current Ratio?
How is the Current Ratio calculated for WuXi Biologics (Cayman) Inc. (2269.HK)?
What is the highest Current Ratio for WuXi Biologics (Cayman) Inc. (2269.HK)?
What is the 3-year average Current Ratio for WuXi Biologics (Cayman) Inc. (2269.HK)?
What is the 5-year average Current Ratio for WuXi Biologics (Cayman) Inc. (2269.HK)?
How does the current Current Ratio for WuXi Biologics (Cayman) Inc. (2269.HK) compare to its historical average?